Simplex Trading’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-328
Closed -$6K 11062
2022
Q2
$6K Buy
328
+323
+6,460% +$8.08K ﹤0.01% 8764
2022
Q1
$0 Buy
+5
New +$180 ﹤0.01% 11567
2021
Q4
Sell
-718
Closed -$37.8K 11630
2021
Q3
$62K Buy
718
+3
+0.4% +$213 ﹤0.01% 7270
2021
Q2
$62K Buy
715
+217
+44% +$20.6K ﹤0.01% 7391
2021
Q1
$56K Buy
498
+497
+49,700% +$55.1K ﹤0.01% 6475
2020
Q4
$0 Buy
+1
New +$37 ﹤0.01% 9213
2019
Q2
Sell
-48
Closed -$16.9K 7927
2019
Q1
$22K Buy
48
+43
+860% +$16.7K ﹤0.01% 5661
2018
Q4
$1K Buy
+5
New +$1.2K ﹤0.01% 6809
2018
Q2
Sell
-3
Closed -$553 7976
2018
Q1
$0 Sell
3
-70
-96% -$13.7K ﹤0.01% 6999
2017
Q4
$17K Sell
73
-82
-53% -$17.1K ﹤0.01% 3462
2017
Q3
$31K Buy
+155
New +$28.5K ﹤0.01% 2764
2016
Q4
Sell
-129
Closed -$44K 6660
2016
Q3
$44K Buy
129
+50
+63% +$17.5K ﹤0.01% 2213
2016
Q2
$25K Buy
+79
New +$28.4K ﹤0.01% 2712

Other funds holding CSCI

Simplex Trading's CSCI Position: Q3 2022 in Review

Simplex Trading sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2022, closing a stake of 328 shares — an estimated $6K sold.

Simplex Trading first reported a position in CSCI in Q2 2016 and held it in 13 quarters. The position peaked at $62K in Q3 2021. 12 funds tracked by Wall St. Rank hold CSCI as of Q3 2022.

  • Simplex Trading reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Simplex Trading sold 328 COSCIENS Biopharma Inc. Common Stock shares in Q3 2022, an estimated $6K.
  • Simplex Trading first reported a position in COSCIENS Biopharma Inc. Common Stock in Q2 2016 and held it in 13 quarters.
  • Simplex Trading's COSCIENS Biopharma Inc. Common Stock position peaked at $62K in Q3 2021.
  • 12 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2022.

Based on Simplex Trading's 13F filing for Q3 2022, filed 4 Nov 2022.